![EC Meijer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van EC Meijer
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Leids Universitair Medisch Centrum
![]() Leids Universitair Medisch Centrum Hospital/Nursing ManagementHealth Services Leids Universitair Medisch Centrum provides medical research, patient care, training, and education. The firm offers fundamental medical and applied clinical research. The company was founded in 1996 and is headquartered in Leiden, the Netherlands.
7
| Private Company | Hospital/Nursing Management | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met EC Meijer via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
enGene, Inc.
![]() enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | Hospital/Nursing Management | Corporate Officer/Principal | |
De Ruiter Seeds Group BV
![]() De Ruiter Seeds Group BV Agricultural Commodities/MillingProcess Industries De Ruiter Seeds Group BV operates as a holding company with interests in vegetable seed breeding companies. The company works with crops such as tomatoes, melons, cucumbers, peppers, and rootstock. It was founded in July, 1945 by Wouter de Ruiter and is headquartered in Bergschenhoek, the Netherlands | Agricultural Commodities/Milling | Director/Board Member | |
Newlight Technologies LLC
![]() Newlight Technologies LLC BiotechnologyHealth Technology Newlight Technologies LLC provides greenhouse gas-to-plastic bioconversion technology services. It produces thermoplastics from air and methane emissions that match the performance of oil-based plastics. The company was founded by Markus D. Herrema and Kenton Kimmel in 2003 and is headquartered in Huntington Beach, CA. | Biotechnology | Director/Board Member | |
WESSANEN | Food: Major Diversified | Director of Finance/CFO | |
GENMAB A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The Scripps Research Institute
![]() The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal | |
Nuon NV (Noord-Holland)
![]() Nuon NV (Noord-Holland) Electric UtilitiesUtilities Nuon NV specialises in the generation, marketing and distribution of electricity, gas and heat. Its operations are divided into three segments such as the Distribution & Sales, Production and Trade and Grid Management. The company engages in the management and operation of energy-intensive industrial estates and street lighting activities. It has operations in the Netherlands, Belgium and Germany. Nuon is headquartered in Amsterdam, the Netherlands. | Electric Utilities | Director of Finance/CFO | |
Dr. Reddy's Research & Development BV
![]() Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
University of San Diego | College/University | Doctorate Degree | |
University of Amsterdam | College/University | Doctorate Degree Doctorate Degree | |
University of Leiden | College/University | Doctorate Degree | |
University of Utrecht | College/University | Doctorate Degree | |
Forbion Capital Partners Management Holding BV
![]() Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor | |
MRC GLOBAL INC. | Wholesale Distributors | Director/Board Member | |
Shell International BV
![]() Shell International BV Integrated OilEnergy Minerals Part of Shell Plc, Shell International BV is a Dutch company that produces oil and gases. The company is based in The Hague, Netherlands. | Integrated Oil | Director/Board Member | |
Commissie Voor De Milieueffectrapportage MER | Chairman | ||
Hookipa Biotech AG
![]() Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member | |
UNIQURE N.V. | Biotechnology | Founder | |
Stedin Holding NV
![]() Stedin Holding NV Electric UtilitiesUtilities Stedin Holding BV operates as a financial holding company with activities in the energy sector. The company is headquartered in Rotterdam, the Netherlands. | Electric Utilities | Chairman | |
Staten Biotechnology BV
![]() Staten Biotechnology BV BiotechnologyHealth Technology Staten Biotechnology BV develops drugs for the treatment of dyslipidemia. The company was founded by Paul da Silva Jardine, Daniel Rader and Alan Tall in 2014 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member | |
LAVA THERAPEUTICS N.V. | Biotechnology | Chief Tech/Sci/R&D Officer | |
HOOKIPA PHARMA INC. | Biotechnology | Director/Board Member | |
Covicept Therapeutics, Inc.
![]() Covicept Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Covicept Therapeutics, Inc. is a newly founded company based in California, USA. Covicept Therapeutics is focused on developing drugs to treat diseases caused by a variety of RNA viruses, including SARS-CoV-2. The American company is backed by $2.30 million in seed funding and operational support from leading European VC firm Forbion. Covicept is developing PSJ-539, a small molecule that inhibits attachment, infection, and replication of SARS-CoV-2 and other RNA viruses. PSJ-539 has shown good tolerability and high potency with excellent and high biodistribution to tissues, including the lungs, in humans, allowing for relatively low daily doses. PSJ-539 also inhibits fibrosis, a property that may be valuable for patients infected with SARS-CoV-2, both short term and long-term. The unique mechanism of action of PSJ-539 may prevent or minimize the development of resistance to vaccines and antiviral medications. The company was founded by Sam Tsimikas, Philip Gordts, and Jeffrey Esko. Sam Tsimikas has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
VectorY BV
![]() VectorY BV Miscellaneous Commercial ServicesCommercial Services VectorY BV is a biotech company based in Amsterdam, Netherlands, that is dedicated to developing transformative medicines for people with neurodegenerative diseases such as ALS, Huntington's, and Parkinson's. VectorY's platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS, enabling long-lasting CNS treatment after a single administration using cutting-edge antibody, AAV, and manufacturing technologies. The Dutch company's unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing, and neuroscience drives the rapid development of much-needed disease-modifying therapies for neurodegenerative diseases. The company was founded by Sander J. van Deventer and Pavlina Konstantinova, with Sander J. van Deventer serving as the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
The Antibody Society | Chairman | ||
Sparring Bioconsult BV | Chief Executive Officer | ||
Transmark Holdings NV
![]() Transmark Holdings NV Industrial MachineryProducer Manufacturing Transmark Holdings NV operates as a holding company with interest in distribution of valves, instrumentation and ancillary flow control equipment. The firm designs, manufactures, and services umbilical- or tether systems for use on ROVs/ROTs and cables for the power and control of installed subsea components, such as wellhead systems. The company was founded in 1956 and is headquartered in Amsterdam, the Netherlands. | Industrial Machinery | Director/Board Member | |
NewAmsterdam Pharma BV
![]() NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Founder |
Statistieken
Internationaal
Nederland | 23 |
Verenigde Staten | 11 |
Canada | 3 |
Denemarken | 3 |
Duitsland | 2 |
Sectoraal
Health Technology | 15 |
Consumer Services | 6 |
Distribution Services | 4 |
Commercial Services | 4 |
Health Services | 3 |
Operationeel
Director/Board Member | 24 |
Corporate Officer/Principal | 9 |
Chairman | 5 |
Chief Tech/Sci/R&D Officer | 5 |
Doctorate Degree | 5 |